UroGen Pharma
URGN
$13.22
Share price
0.08%
Change (1 day)
11.09%
Change (1 year)
Categories
P/S ratio for UroGen Pharma (URGN)
P/S ratio as of May 2024 (TTM): 5.77
According to UroGen Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.7703. At the end of 2023 the company had a P/S ratio of 5.60.
P/S ratio history for UroGen Pharma from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.60 | 75.89% |
| 2022 | 3.18 | -28.43% |
| 2021 | 4.45 | -86.87% |
| 2020 | 33.9 | -99.91% |
| 2019 | > 1000 | 6197.46% |
| 2018 | 619 | 929.77% |
| 2017 | 60.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |